BioNTech will supply pumitamig, a PD-L1/VEGF-A bispecific antibody co-developed with Bristol Myers Squibb, while Boehringer Ingelheim will act as the regulatory sponsor of a Phase Ib/II study
The study’s multi-technology design is intended to improve reproducibility, strengthen regulatory-grade evidence generation
Workshop on ECG interpretation also marks launch of “Handbook on ECGs – Volume 2”
A brand from Opella will be part of the official NASA astronaut formulary
The centre offers a full spectrum of FDA-approved services, including physiotherapy, occupational therapy, speech and language therapy, and aqua therapy
Paves the way for next-gen ultra-precise gas sensing
The license is valid for five years, effective from April 9, 2026
MoU aims to strengthen academia-industry collaboration in healthcare research and innovation
The three-day conference is expected to bring together more than 3,000 physiotherapists, clinicians, researchers, academicians, and students
On-site medical room brings preventive care, routine consultations, and diagnostics closer to residents
Subscribe To Our Newsletter & Stay Updated
